首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1738563

2026 年至 2032 年腹腔鏡設備市場（按類型、應用、最終用戶和地區）

Laparoscopy Devices Market By Type (Laparoscopes, Energy Devices, Insufflators, Access Devices), Application (Ariatric Surgery, General Surgery, Gynecological Surgery, Urological Surgery), End-User (Hospitals, Ambulatory Centers), & Region for 2026-2032

出版日期: 2025年05月12日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

腹腔鏡設備市場評估—2026-2032

微創手術技術日益偏好越來越多的患者選擇腹腔鏡手術而非傳統開放性手術，因為腹腔鏡手術具有術後疼痛輕、恢復時間短、疤痕少等諸多優勢。預計2023年市場規模將超過154億美元，到2032年將達到276.7億美元。

此外，高清攝影機和機器人輔助手術設備等技術創新正在提高腹腔鏡手術的精確度和有效性。此外，肥胖和胃腸道疾病等慢性疾病的日益流行正在推動對腹腔鏡手術的需求，導致市場不斷擴大，預計從 2026 年到 2032 年的複合年成長率約為 8.39%。

腹腔鏡設備市場定義/概述

腹腔鏡設備是用於微創外科手術的專用器械，外科醫師借助攝影機和各種手術器械，透過小切口進行手術。這些器械的常見應用包括減重手術、婦科手術、泌尿系統手術和胃腸手術。與傳統的開放性手術相比，腹腔鏡設備具有恢復時間短、術後疼痛輕、疤痕小等特性。機器人輔助系統、增強影像技術以及人工智慧等技術進步可望改善手術效果，擴大腹腔鏡手術的範圍，使腹腔鏡設備市場前景看好。

慢性病盛行率上升會推動腹腔鏡設備市場的發展嗎？

慢性病盛行率的上升推動了腹腔鏡設備市場的成長，因為這些疾病通常需要手術介入才能有效治療。肥胖、糖尿病和胃腸道疾病等慢性疾病在全球日益普遍。根據美國疾病管制與預防中心 (CDC) 的數據，到 2021 年，美國約有 42.4% 的成年人將被歸類為肥胖，這意味著大量人口可以從腹腔鏡減重手術中受益。此外，世界衛生組織 (WHO) 報告稱，消化器官系統疾病是全球主要發病原因之一，這進一步推動了對腹腔鏡設備輔助微創手術的需求。

此外，向早期療育和預防性醫療保健的轉變正在創造有利於腹腔鏡技術應用的環境。隨著醫療保健系統優先考慮經濟高效的治療方案和改善患者預後，腹腔鏡手術因其住院時間縮短、恢復時間更快等優勢，正逐漸被接受。

監管挑戰會阻礙腹腔鏡設備市場的成長嗎？

監管環境無疑會阻礙腹腔鏡器械市場的成長，因為製造商必須應對不同地區複雜的合規要求。例如，在美國，食品藥物管理局(FDA) 對醫療設備核准有著嚴格的規定，這可能導致核准流程冗長且成本高昂。這種官僚主義障礙可能會減緩創新腹腔鏡技術的市場推廣，並影響製造商快速回應不斷變化的醫療保健需求和市場需求的能力。

此外，臨床試驗和大量的文件要求可能會給小公司帶來資源壓力，限制其與擁有更完善監管策略的大公司競爭的能力。此外，隨著全球監管機構日益重視病患安全和產品功效，製造商可能面臨更嚴格的上市後裝置審查。這可能導致更頻繁的產品召回和安全警告，這不僅會影響消費者信心，還會給主要企業帶來財務負擔。

The growing preference for minimally invasive surgical techniques. Patients are increasingly choosing laparoscopic operations over traditional open surgeries because they offer various benefits such as less postoperative pain, shorter recovery times, and less scarring is surpassing USD 15.4 Billion in 2023 and reaching USD 27.67 Billion by 2032.

Furthermore, technological breakthroughs such as high-definition cameras and robotic-assisted surgical devices are improving the precision and efficacy of laparoscopic treatments. Furthermore, the increased prevalence of chronic conditions such as obesity and gastrointestinal problems is driving up demand for laparoscopic procedures, resulting in continuous market expansion is expected to grow at a CAGR of 8.39% about from 2026 to 2032.

Laparoscopy Devices Market: Definition/ Overview

Laparoscopy devices are specialized instruments used in minimally invasive surgical procedures, enabling surgeons to perform operations through small incisions with the aid of a camera and various surgical tools. Common applications of these devices include bariatric surgery, gynecological procedures, urological surgeries, and gastrointestinal surgeries, allowing for reduced recovery times, less postoperative pain, and minimized scarring compared to traditional open surgery. The future of the Laparoscopy Devices Market looks promising, driven by technological advancements such as robotic-assisted systems, enhanced imaging technologies, and the integration of artificial intelligence, which are expected to improve surgical outcomes and broaden the range of procedures performed laparoscopically.

Will Rising Prevalence of Chronic Diseases is Propelling the Laparoscopy Devices Market?

The rising prevalence of chronic diseases is indeed propelling the growth of the Laparoscopy Devices Market, as these conditions often require surgical intervention for effective management. Chronic diseases such as obesity, diabetes, and gastrointestinal disorders are becoming increasingly common worldwide. According to the Centers for Disease Control and Prevention (CDC), approximately 42.4% of adults in the United States were classified as obese in 2021, highlighting a significant population that may benefit from laparoscopic bariatric surgery. Additionally, the World Health Organization (WHO) reports that digestive diseases are among the leading causes of morbidity globally, further driving the demand for minimally invasive surgical procedures that laparoscopic devices facilitate.

Furthermore, the shift towards early intervention and preventive healthcare is fostering an environment conducive to the adoption of laparoscopic techniques. As healthcare systems prioritize cost-effective treatments and improved patient outcomes, laparoscopic surgery has gained traction due to its associated benefits, such as shorter hospital stays and quicker recovery times.

Will Regulatory Challenges Hamper the Growth of the Laparoscopy Devices Market?

Regulatory challenges are indeed poised to hamper the growth of the Laparoscopy Devices Market, as manufacturers must navigate a complex landscape of compliance requirements that vary by region. In the United States, for example, the Food and Drug Administration (FDA) has stringent regulations governing the approval of medical devices, which can lead to lengthy and costly approval processes. This bureaucratic hurdle can delay the introduction of innovative laparoscopic technologies to the market, impacting the ability of manufacturers to respond swiftly to evolving healthcare needs and market demands.

Additionally, the requirement for clinical trials and extensive documentation can strain the resources of smaller companies, limiting their capacity to compete with larger firms that have more robust regulatory strategies. Moreover, as regulatory bodies worldwide intensify their focus on patient safety and product efficacy, manufacturers may face increased scrutiny of their devices post-market. This can lead to more frequent product recalls or safety alerts, which not only affect consumer trust but also impose financial burdens on companies.

Category-Wise Acumens

Will Increasing Adoption of Energy Devices Boost the Laparoscopy Devices Market?

The increasing adoption of energy devices in laparoscopic surgeries is set to significantly boost the laparoscopic devices market. Energy devices, such as electrosurgical generators and advanced ultrasonic devices, play a crucial role in enhancing surgical efficiency by providing precise control over tissue cutting and coagulation. These devices minimize the risk of thermal damage to surrounding tissues, resulting in fewer complications and improved patient outcomes.

As more healthcare facilities recognize the advantages of these technologies, the demand for energy devices in laparoscopic procedures is expected to rise, driving overall market growth. Moreover, the trend toward minimally invasive surgeries is further propelling the adoption of energy devices. Surgeons increasingly prefer these devices due to their ability to streamline surgical processes and reduce operating times.

The insufflators are the fastest growing segment, driven by the rising adoption of minimally invasive surgical techniques and the growing need for effective carbon dioxide delivery to create and maintain a pneumoperitoneum.

Will Widespread Availability of Bariatric Surgery Fuel the Laparoscopy Devices Market?

The widespread availability of bariatric surgery is set to significantly fuel the Laparoscopy Devices Market. As obesity rates continue to rise globally, with the World Health Organization reporting that over 1.9 billion adults were classified as overweight in 2021, the demand for effective weight-loss solutions, particularly surgical interventions, has increased. Laparoscopic bariatric procedures, such as gastric bypass and sleeve gastrectomy, are favored for their minimally invasive nature, leading to shorter recovery times, reduced postoperative pain, and fewer complications.

This growing acceptance and preference for bariatric surgery among both healthcare providers and patients are driving an increased demand for advanced laparoscopic devices, which are essential for performing these procedures effectively. Moreover, the healthcare industry's focus on improving patient outcomes and reducing healthcare costs is further propelling the growth of the Laparoscopy Devices Market. As more hospitals and surgical centers adopt laparoscopic techniques for bariatric surgeries, the need for specialized devices will continue to rise.

The Gynecological Surgery is the fastest-growing segment, driven by a rise in conditions such as endometriosis, fibroids, and infertility treatments that require laparoscopic interventions.

Country/Region-wise

Will the Technological Advancement in North America Drive the Expansion of The Laparoscopy Devices Market?

Technological advancements are poised to significantly drive the expansion of the Laparoscopy Devices Market in North America. Innovations such as enhanced imaging systems, robotic-assisted surgery, and advanced surgical instruments are making minimally invasive procedures more efficient and safer for patients. For instance, the adoption of robotic surgical systems, which saw a 15% increase in utilization rates across hospitals in 2023 according to the American College of Surgeons, is enhancing the precision of laparoscopic surgeries, thereby increasing the overall demand for these devices.

Additionally, the increasing prevalence of chronic diseases such as obesity and gastrointestinal disorders is driving the demand for laparoscopic surgeries, as these procedures offer shorter recovery times and fewer complications compared to traditional surgeries. The U.S. Centers for Disease Control and Prevention (CDC) reports that approximately 42.4% of adults in the United States were classified as obese in 2021, a statistic that underscores the need for effective surgical interventions.

Will Increasing Number of Well-Equipped Hospitals in Asia Pacific Propel the Laparoscopy Devices Market?

The increasing number of well-equipped hospitals in the Asia Pacific region is expected to significantly propel the Laparoscopy Devices Market. According to the World Health Organization (WHO), the number of hospitals in Asia has grown rapidly, with an increase of over 30% in the last decade, largely due to rising healthcare expenditures and investments in advanced medical technologies. This surge in healthcare infrastructure is accompanied by a growing emphasis on minimally invasive surgical procedures, as they offer benefits such as reduced recovery times and lower complication rates.

Furthermore, government initiatives aimed at improving healthcare accessibility and quality are driving this trend. For instance, the Indian government's National Health Policy aims to increase the number of surgical procedures conducted in hospitals, with a target of reaching a surgical volume of 13 million by 2025. This focus on expanding surgical capabilities, along with a reported 12% increase in the budget allocation for healthcare in countries like Indonesia and Malaysia, further underscores the region's commitment to enhancing healthcare services.

Competitive Landscape

The competitive landscape of the Laparoscopy Devices Market is characterized by a mix of established players and emerging startups, each focusing on innovative features such as real-time tracking, integration with IoT devices, and user-friendly interfaces. Companies are increasingly investing in research and development to enhance product offerings and improve customer service, creating a dynamic and rapidly evolving market environment.

Some of the prominent players operating in the Laparoscopy Devices Market include Karl Storz SE & Co, Olympus Corporation, Medtronic plc, Braun Aesculap, Stryker Corporation, Richard Wolf GmbH, Ethicon Inc., Smith & Nephew plc, Cook Medical Incorporated, ConMed Corporation, Genesis MedTech, Johnson & Johnson, Boston Scientific Corporation, Shenzen Midray Bio-medical Electronics Co. Ltd., Microline Surgical.

Latest Developments

In August 2024 Medtronic announced the launch of its new HARMONIC(TM) PRIME ultrasonic scalpel, designed to improve precision and control during laparoscopic surgeries. This device integrates advanced technology to minimize thermal spread and enhance tissue preservation, aligning with the growing demand for minimally invasive surgical solutions.
In July 2024 Johnson & Johnson completed its acquisition of Auris Health, a robotics company focused on advancing minimally invasive surgical techniques. This acquisition aims to strengthen Johnson & Johnson's position in the laparoscopic devices market by integrating robotics with laparoscopic technology, allowing for enhanced surgical capabilities and improved patient outcomes.
In June 2024 Stryker introduced its IMPACT(TM) 3D Camera System, which provides enhanced visualization and depth perception for surgeons during laparoscopic procedures. This system features advanced imaging technology that aids in better identification of anatomical structures, improving surgical precision and patient safety.

1 INTRODUCTION OF GLOBAL LAPAROSCOPY DEVICES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL LAPAROSCOPY DEVICES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL LAPAROSCOPY DEVICES MARKET, BY TYPE

5.1 Overview
5.2 Laparoscopes
5.3 Energy Devices
5.4 Insufflators
5.5 Access Devices

6 GLOBAL LAPAROSCOPY DEVICES MARKET, BY APPLICATION

6.1 Overview
6.2 Bariatric Surgery
6.3 General Surgery
6.4 Gynecological Surgery
6.5 Urological Surgery

7 GLOBAL LAPAROSCOPY DEVICES MARKET, BY END-USER

7.1 Overview
7.2 Hospitals
7.3 Ambulatory Centers

8 GLOBAL LAPAROSCOPY DEVICES MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL LAPAROSCOPY DEVICES MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Karl Storz SE & Co
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Olympus Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Medtronic plc
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Braun Aesculap
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Stryker Corporation
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Richard Wolf GmbH
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Ethicon Inc.
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Smith & Nephew plc
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Cook Medical Incorporated
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 ConMed Corporation
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.11 Genesis MedTech
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments
10.12 Johnson & Johnson
- 10.12.1 Overview
- 10.12.2 Financial Performance
- 10.12.3 Product Outlook
- 10.12.4 Key Developments
10.13 Boston Scientific Corporation
- 10.13.1 Overview
- 10.13.2 Financial Performance
- 10.13.3 Product Outlook
- 10.13.4 Key Developments
10.14 Shenzen Midray Bio-medical Electronics Co. Ltd.
- 10.14.1 Overview
- 10.14.2 Financial Performance
- 10.14.3 Product Outlook
- 10.14.4 Key Developments
10.15 Microline Surgical
- 10.15.1 Overview
- 10.15.2 Financial Performance
- 10.15.3 Product Outlook
- 10.15.4 Key Developments